{"id":31537,"date":"2025-03-03T09:32:39","date_gmt":"2025-03-03T08:32:39","guid":{"rendered":"https:\/\/ggba.swiss\/atanis-biotech-secures-usd-2-million-for-its-fast-pase-allergy-test\/"},"modified":"2025-03-03T09:36:19","modified_gmt":"2025-03-03T08:36:19","slug":"atanis-biotech-decroche-usd-2-millions-pour-son-test-de-diagnostic-des-allergies","status":"publish","type":"post","link":"https:\/\/ggba.swiss\/fr\/atanis-biotech-decroche-usd-2-millions-pour-son-test-de-diagnostic-des-allergies\/","title":{"rendered":"ATANIS Biotech d\u00e9croche USD 2 millions pour son test de diagnostic des allergies"},"content":{"rendered":"\n<p><a href=\"https:\/\/www.atanis-biotech.com\/\">ATANIS Biotech<\/a>, une soci\u00e9t\u00e9 de biotechnologie bas\u00e9e \u00e0 Berne et sp\u00e9cialis\u00e9e dans le diagnostic fonctionnel des allergies, a remport\u00e9 la phase 2 du <a href=\"https:\/\/www.foodallergy.org\/research-innovation\/accelerating-innovation\/pioneering-advances-diagnosis\/fare-innovation-award\">FARE Innovation Award Diagnostic Challenge<\/a>. Le test d&rsquo;allergie FAST-PASE de la soci\u00e9t\u00e9, un test fonctionnel d&rsquo;activation ex vivo des mastocytes, a \u00e9t\u00e9 s\u00e9lectionn\u00e9 par FARE (Food Allergy Research &amp; Education) apr\u00e8s une \u00e9valuation scientifique rigoureuse, et a obtenu un financement de 2 millions de dollars pour acc\u00e9l\u00e9rer sa commercialisation et son adoption clinique.<\/p>\n\n\n\n<p>Fond\u00e9e en tant que spin-off de l&rsquo;Universit\u00e9 de Berne, ATANIS s&rsquo;attache \u00e0 r\u00e9volutionner les tests d&rsquo;allergie en rempla\u00e7ant les m\u00e9thodes in vivo obsol\u00e8tes et risqu\u00e9es par sa technologie exclusive FAST-PASE. Ce test innovant utilise des mastocytes modifi\u00e9s qui reproduisent les r\u00e9actions allergiques naturelles lorsqu&rsquo;ils sont expos\u00e9s \u00e0 des allerg\u00e8nes, offrant ainsi une alternative plus s\u00fbre, \u00e9volutive et tr\u00e8s pr\u00e9cise aux tests oraux traditionnels (OFC). Dans une r\u00e9cente \u00e9tude d&rsquo;utilit\u00e9 clinique, FAST-PASE a d\u00e9montr\u00e9 une pr\u00e9cision de plus de 95 % dans le diagnostic des allergies aux arachides.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\">Une validation clinique et une reconnaissance croissante de l&rsquo;industrie<\/h4>\n\n\n\n<p>La CEO de FARE, le Dr Sung Poblete, a soulign\u00e9 l&rsquo;importance du prix : \u00ab Bien que les OFC jouent un r\u00f4le essentiel dans le d\u00e9veloppement de nouveaux traitements dans les milieux de recherche et le diagnostic des allergies alimentaires en milieu clinique, ils impliquent l&rsquo;ingestion supervis\u00e9e d&rsquo;un allerg\u00e8ne suspect\u00e9 et comportent donc un certain risque d&rsquo;anaphylaxie pour le patient. Nous sommes heureux d&rsquo;annoncer qu&rsquo;ATANIS Biotech est le tout nouveau laur\u00e9at du prix de l&rsquo;innovation Diagnostic Challenge. \u00bb<\/p>\n\n\n\n<p>Ce financement permettra de soutenir le d\u00e9veloppement de FAST-PASE dans de multiples indications allergiques, ATANIS collaborant avec des experts mondiaux de premier plan dans le domaine des allergies, notamment le Mount Sinai, le Baylor College of Medicine, le SickKids Toronto et l&rsquo;Universit\u00e9 de Berne.<\/p>\n\n\n\n<p>Le CEO d&rsquo;ATANIS, le professeur Jean-Pierre Kinet, a soulign\u00e9 l&rsquo;impact strat\u00e9gique de ce partenariat : \u00ab Je suis ravi de m&rsquo;associer \u00e0 une organisation aussi r\u00e9put\u00e9e que FARE et \u00e0 des scientifiques et m\u00e9decins de si haut niveau pour poursuivre notre mission qui consiste \u00e0 proposer des tests plus s\u00fbrs aux patients allergiques du monde entier. \u00bb<\/p>\n\n\n\n<figure class=\"wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio\"><div class=\"wp-block-embed__wrapper\">\n<iframe loading=\"lazy\" title=\"The Startup Ecosystem in the Canton of Bern\" width=\"500\" height=\"281\" src=\"https:\/\/www.youtube.com\/embed\/d6YxuxfFipc?feature=oembed\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share\" referrerpolicy=\"strict-origin-when-cross-origin\" allowfullscreen><\/iframe>\n<\/div><\/figure>\n","protected":false},"excerpt":{"rendered":"<p>La start-up bernoise ATANIS Biotech a remport\u00e9 la phase 2 du FARE Innovation Award Diagnostic Challenge, obtenant ainsi USD 2 millions pour faire progresser son test d&rsquo;allergie FAST-PASE.<\/p>\n","protected":false},"author":6,"featured_media":31533,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"mc4wp_mailchimp_campaign":[],"footnotes":""},"categories":[843],"tags":[1169,1148,1166,1188],"class_list":["post-31537","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-sciences-de-la-vie","tag-biotech-fr-2","tag-financing-fr-2","tag-food-beverages-fr-2","tag-healthcare-fr-2"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>ATANIS Biotech d\u00e9croche USD 2M pour le diagnostic des allergies<\/title>\n<meta name=\"description\" content=\"La start-up bernoise ATANIS Biotech a remport\u00e9 USD 2 millions pour faire progresser son test d&#039;allergie FAST-PASE.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ggba.swiss\/fr\/atanis-biotech-decroche-usd-2-millions-pour-son-test-de-diagnostic-des-allergies\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ATANIS Biotech d\u00e9croche USD 2M pour le diagnostic des allergies\" \/>\n<meta property=\"og:description\" content=\"La start-up bernoise ATANIS Biotech a remport\u00e9 USD 2 millions pour faire progresser son test d&#039;allergie FAST-PASE.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ggba.swiss\/fr\/atanis-biotech-decroche-usd-2-millions-pour-son-test-de-diagnostic-des-allergies\/\" \/>\n<meta property=\"og:site_name\" content=\"Greater Geneva Bern area\" \/>\n<meta property=\"article:published_time\" content=\"2025-03-03T08:32:39+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-03-03T08:36:19+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ggba.swiss\/app\/uploads\/2025\/03\/Atanis-Biotech-USD-2-million-1180x811-1.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"1180\" \/>\n\t<meta property=\"og:image:height\" content=\"811\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Pierre-Yves Oehrli\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Pierre-Yves Oehrli\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/ggba.swiss\/fr\/atanis-biotech-decroche-usd-2-millions-pour-son-test-de-diagnostic-des-allergies\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/atanis-biotech-decroche-usd-2-millions-pour-son-test-de-diagnostic-des-allergies\/\"},\"author\":{\"name\":\"Pierre-Yves Oehrli\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"headline\":\"ATANIS Biotech d\u00e9croche USD 2 millions pour son test de diagnostic des allergies\",\"datePublished\":\"2025-03-03T08:32:39+00:00\",\"dateModified\":\"2025-03-03T08:36:19+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/atanis-biotech-decroche-usd-2-millions-pour-son-test-de-diagnostic-des-allergies\/\"},\"wordCount\":411,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/atanis-biotech-decroche-usd-2-millions-pour-son-test-de-diagnostic-des-allergies\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2025\/03\/Atanis-Biotech-USD-2-million-1180x811-1.jpeg\",\"keywords\":[\"Biotech\",\"Financing\",\"Food &amp; Beverages\",\"Healthcare\"],\"articleSection\":[\"Sciences de la vie\"],\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/ggba.swiss\/fr\/atanis-biotech-decroche-usd-2-millions-pour-son-test-de-diagnostic-des-allergies\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ggba.swiss\/fr\/atanis-biotech-decroche-usd-2-millions-pour-son-test-de-diagnostic-des-allergies\/\",\"url\":\"https:\/\/ggba.swiss\/fr\/atanis-biotech-decroche-usd-2-millions-pour-son-test-de-diagnostic-des-allergies\/\",\"name\":\"ATANIS Biotech d\u00e9croche USD 2M pour le diagnostic des allergies\",\"isPartOf\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/atanis-biotech-decroche-usd-2-millions-pour-son-test-de-diagnostic-des-allergies\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/atanis-biotech-decroche-usd-2-millions-pour-son-test-de-diagnostic-des-allergies\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2025\/03\/Atanis-Biotech-USD-2-million-1180x811-1.jpeg\",\"datePublished\":\"2025-03-03T08:32:39+00:00\",\"dateModified\":\"2025-03-03T08:36:19+00:00\",\"author\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"description\":\"La start-up bernoise ATANIS Biotech a remport\u00e9 USD 2 millions pour faire progresser son test d'allergie FAST-PASE.\",\"breadcrumb\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/atanis-biotech-decroche-usd-2-millions-pour-son-test-de-diagnostic-des-allergies\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ggba.swiss\/fr\/atanis-biotech-decroche-usd-2-millions-pour-son-test-de-diagnostic-des-allergies\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/ggba.swiss\/fr\/atanis-biotech-decroche-usd-2-millions-pour-son-test-de-diagnostic-des-allergies\/#primaryimage\",\"url\":\"https:\/\/ggba.swiss\/app\/uploads\/2025\/03\/Atanis-Biotech-USD-2-million-1180x811-1.jpeg\",\"contentUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2025\/03\/Atanis-Biotech-USD-2-million-1180x811-1.jpeg\",\"width\":1180,\"height\":811,\"caption\":\"ATANIS Biotech r\u00e9volutionne le diagnostic des allergies avec son test FAST-PASE fonctionnel et tr\u00e8s pr\u00e9cis, qui offre une alternative plus s\u00fbre aux tests de provocation orale. | \u00a9 ATANIS Biotech\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ggba.swiss\/fr\/atanis-biotech-decroche-usd-2-millions-pour-son-test-de-diagnostic-des-allergies\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ggba.swiss\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ATANIS Biotech d\u00e9croche USD 2 millions pour son test de diagnostic des allergies\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\",\"url\":\"https:\/\/staging.ggba.swiss\/en\/\",\"name\":\"Greater Geneva Bern area\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\",\"name\":\"Pierre-Yves Oehrli\",\"url\":\"https:\/\/ggba.swiss\/fr\/author\/pierre-yves-oehrli\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ATANIS Biotech d\u00e9croche USD 2M pour le diagnostic des allergies","description":"La start-up bernoise ATANIS Biotech a remport\u00e9 USD 2 millions pour faire progresser son test d'allergie FAST-PASE.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ggba.swiss\/fr\/atanis-biotech-decroche-usd-2-millions-pour-son-test-de-diagnostic-des-allergies\/","og_locale":"fr_FR","og_type":"article","og_title":"ATANIS Biotech d\u00e9croche USD 2M pour le diagnostic des allergies","og_description":"La start-up bernoise ATANIS Biotech a remport\u00e9 USD 2 millions pour faire progresser son test d'allergie FAST-PASE.","og_url":"https:\/\/ggba.swiss\/fr\/atanis-biotech-decroche-usd-2-millions-pour-son-test-de-diagnostic-des-allergies\/","og_site_name":"Greater Geneva Bern area","article_published_time":"2025-03-03T08:32:39+00:00","article_modified_time":"2025-03-03T08:36:19+00:00","og_image":[{"width":1180,"height":811,"url":"https:\/\/ggba.swiss\/app\/uploads\/2025\/03\/Atanis-Biotech-USD-2-million-1180x811-1.jpeg","type":"image\/jpeg"}],"author":"Pierre-Yves Oehrli","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Pierre-Yves Oehrli","Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ggba.swiss\/fr\/atanis-biotech-decroche-usd-2-millions-pour-son-test-de-diagnostic-des-allergies\/#article","isPartOf":{"@id":"https:\/\/ggba.swiss\/fr\/atanis-biotech-decroche-usd-2-millions-pour-son-test-de-diagnostic-des-allergies\/"},"author":{"name":"Pierre-Yves Oehrli","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"headline":"ATANIS Biotech d\u00e9croche USD 2 millions pour son test de diagnostic des allergies","datePublished":"2025-03-03T08:32:39+00:00","dateModified":"2025-03-03T08:36:19+00:00","mainEntityOfPage":{"@id":"https:\/\/ggba.swiss\/fr\/atanis-biotech-decroche-usd-2-millions-pour-son-test-de-diagnostic-des-allergies\/"},"wordCount":411,"commentCount":0,"image":{"@id":"https:\/\/ggba.swiss\/fr\/atanis-biotech-decroche-usd-2-millions-pour-son-test-de-diagnostic-des-allergies\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2025\/03\/Atanis-Biotech-USD-2-million-1180x811-1.jpeg","keywords":["Biotech","Financing","Food &amp; Beverages","Healthcare"],"articleSection":["Sciences de la vie"],"inLanguage":"fr-FR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/ggba.swiss\/fr\/atanis-biotech-decroche-usd-2-millions-pour-son-test-de-diagnostic-des-allergies\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/ggba.swiss\/fr\/atanis-biotech-decroche-usd-2-millions-pour-son-test-de-diagnostic-des-allergies\/","url":"https:\/\/ggba.swiss\/fr\/atanis-biotech-decroche-usd-2-millions-pour-son-test-de-diagnostic-des-allergies\/","name":"ATANIS Biotech d\u00e9croche USD 2M pour le diagnostic des allergies","isPartOf":{"@id":"https:\/\/staging.ggba.swiss\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ggba.swiss\/fr\/atanis-biotech-decroche-usd-2-millions-pour-son-test-de-diagnostic-des-allergies\/#primaryimage"},"image":{"@id":"https:\/\/ggba.swiss\/fr\/atanis-biotech-decroche-usd-2-millions-pour-son-test-de-diagnostic-des-allergies\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2025\/03\/Atanis-Biotech-USD-2-million-1180x811-1.jpeg","datePublished":"2025-03-03T08:32:39+00:00","dateModified":"2025-03-03T08:36:19+00:00","author":{"@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"description":"La start-up bernoise ATANIS Biotech a remport\u00e9 USD 2 millions pour faire progresser son test d'allergie FAST-PASE.","breadcrumb":{"@id":"https:\/\/ggba.swiss\/fr\/atanis-biotech-decroche-usd-2-millions-pour-son-test-de-diagnostic-des-allergies\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ggba.swiss\/fr\/atanis-biotech-decroche-usd-2-millions-pour-son-test-de-diagnostic-des-allergies\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/ggba.swiss\/fr\/atanis-biotech-decroche-usd-2-millions-pour-son-test-de-diagnostic-des-allergies\/#primaryimage","url":"https:\/\/ggba.swiss\/app\/uploads\/2025\/03\/Atanis-Biotech-USD-2-million-1180x811-1.jpeg","contentUrl":"https:\/\/ggba.swiss\/app\/uploads\/2025\/03\/Atanis-Biotech-USD-2-million-1180x811-1.jpeg","width":1180,"height":811,"caption":"ATANIS Biotech r\u00e9volutionne le diagnostic des allergies avec son test FAST-PASE fonctionnel et tr\u00e8s pr\u00e9cis, qui offre une alternative plus s\u00fbre aux tests de provocation orale. | \u00a9 ATANIS Biotech"},{"@type":"BreadcrumbList","@id":"https:\/\/ggba.swiss\/fr\/atanis-biotech-decroche-usd-2-millions-pour-son-test-de-diagnostic-des-allergies\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ggba.swiss\/fr\/"},{"@type":"ListItem","position":2,"name":"ATANIS Biotech d\u00e9croche USD 2 millions pour son test de diagnostic des allergies"}]},{"@type":"WebSite","@id":"https:\/\/staging.ggba.swiss\/en\/#website","url":"https:\/\/staging.ggba.swiss\/en\/","name":"Greater Geneva Bern area","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Person","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41","name":"Pierre-Yves Oehrli","url":"https:\/\/ggba.swiss\/fr\/author\/pierre-yves-oehrli\/"}]}},"_links":{"self":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/31537","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/comments?post=31537"}],"version-history":[{"count":1,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/31537\/revisions"}],"predecessor-version":[{"id":31539,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/31537\/revisions\/31539"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/media\/31533"}],"wp:attachment":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/media?parent=31537"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/categories?post=31537"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/tags?post=31537"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}